WCNC Verify explains RETA, the weight loss drug people are asking about
A local news explainer on retatrutide, often shortened to RETA, and what is actually known about the drug still in trials.
Recap by typeshit. Full story at WCNC.
A local news explainer on retatrutide, often shortened to RETA, and what is actually known about the drug still in trials.
Recap by typeshit. Full story at WCNC.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
Researchers compared 22,694 first-time semaglutide users with 229,640 controls. Lead author Mille Dybdal Bager says the link shouldn't be read as cause and effect.
WCNC Charlotte talks with a bariatric surgeon about why the drug nicknamed RETA is drawing attention even though it has no FDA approval.
Loading…